SLC8A1 and myocardial infarction: The latter, combined with the current view that the sodium/calcium exchanger 1 (SLC8A1) is expected to mediate effects of pirfenidone on post-myocardial infarction remodeling (Supplemental Table 3), could help link calcium homeostasis effects with the benefits in post-MI LV.